McKesson Corporation (MCK) experienced a slide in its stock performance during the second quarter.

A market update provides information on the stock performance and relevant news for MCK (McKesson Corporation) and AVGO (Broadcom Inc.).

McKesson Corporation (MCK) saw a 50% surge in its stock value, attributed to robust earnings growth and a resilient drug distribution model.

An analysis is provided to determine if McKesson Corporation (MCK) stock is a favorable investment choice at this time.

An analysis highlights factors that position McKesson Corporation (MCK) as a potentially attractive investment opportunity.

McKesson Corporation has announced plans to sell approximately a 13% stake in its Medical-Surgical Solutions business to Apollo. This strategic move involves a significant portion of the unit being acquired by the investment firm.

Analysts are providing their perspectives and ratings on McKesson Corporation (MCK), a healthcare company, with various financial assessments.

McKesson Corporation emphasizes the resilience of its core drug distribution network, asserting its ability to withstand challenges over time.

Articles provide analysis on the stock performance of various companies like CVS Health, Trane Technologies, and McKesson Corporation, comparing them to broader market indexes, alongside general market talk and sentiment.